Luye Pharma Group Stock Probability of Future Pink Sheet Price Finishing Under 0.35
| LYPHF Stock | USD 0.34 0.00 0.00% |
Luye |
Luye Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Luye Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Luye Pharma Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Luye Pharma Group generated a negative expected return over the last 90 days | |
| Luye Pharma Group has some characteristics of a very speculative penny stock | |
| Luye Pharma Group has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.2 B. Net Loss for the year was (134.39 M) with profit before overhead, payroll, taxes, and interest of 3.4 B. | |
| About 35.0% of the company outstanding shares are owned by corporate insiders |
Luye Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Luye Pink Sheet often depends not only on the future outlook of the current and potential Luye Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Luye Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.5 B |
Luye Pharma Technical Analysis
Luye Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Luye Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Luye Pharma Group. In general, you should focus on analyzing Luye Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Luye Pharma Predictive Forecast Models
Luye Pharma's time-series forecasting models is one of many Luye Pharma's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Luye Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Luye Pharma Group
Checking the ongoing alerts about Luye Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Luye Pharma Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Luye Pharma Group generated a negative expected return over the last 90 days | |
| Luye Pharma Group has some characteristics of a very speculative penny stock | |
| Luye Pharma Group has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.2 B. Net Loss for the year was (134.39 M) with profit before overhead, payroll, taxes, and interest of 3.4 B. | |
| About 35.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in Luye Pink Sheet
Luye Pharma financial ratios help investors to determine whether Luye Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Luye with respect to the benefits of owning Luye Pharma security.